Guo, Y., Wang, X., Tian, X., Li, Y., Li, B., Huang, Q., . . . Li, Z. (2012). Tumor-derived hepatocyte growth factor is associated with poor prognosis of patients with glioma and influences the chemosensitivity of glioma cell line to cisplatin in vitro. BioMed Central.
シカゴスタイル引用形Guo, You-feng, Xiao-bing Wang, Xiao-ying Tian, Yang Li, Bin Li, Quan Huang, Meng Zhang, , Zhi Li. Tumor-derived Hepatocyte Growth Factor Is Associated With Poor Prognosis of Patients With Glioma and Influences the Chemosensitivity of Glioma Cell Line to Cisplatin in Vitro. BioMed Central, 2012.
MLA引用形式Guo, You-feng, et al. Tumor-derived Hepatocyte Growth Factor Is Associated With Poor Prognosis of Patients With Glioma and Influences the Chemosensitivity of Glioma Cell Line to Cisplatin in Vitro. BioMed Central, 2012.